| |
Michael J. Magliochetti, Ph.D.
Entrepreneur-in-Residence
Boston, MA
mmagliochetti@oxbio.com |
Michael J. Magliochetti, Ph.D. brings significant business operations, technical and strategic management experience to his role as Entrepreneur-in-Residence at Oxford Bioscience Partners. Dr. Magliochetti was most recently CEO of Rehab Medical Holdings, Inc., an orthopedic medical device company, which was acquired. Previously, he was CEO of HemaMetrics Corporation, a private blood monitoring and diagnostic technology company. Dr. Magliochetti was CEO of UroSurge Corporation, a company specializing in products for the urology market of which a sale transaction was executed. He has held senior positions with the medical device company Haemonetics Corporation; the polymer products company Delta Surprenant, and an assignment with the U.S. Army Research Command. Dr. Magliochetti currently serves on the Advisory Board for the Pediatric New Technology Initiatives Group of Boston Children’s Hospital and on the Board of Directors of Spire Corporation. He has also served as an Adjunct Professor of Biomedical Engineering at the University of Iowa, is a former member of the Iowa Governor’s Industry Executive Roundtable, and has consulted with many early-stage companies in the medical device industry such as BioMorphics, Xorbent, Aquamer, and Access Wellness. He has enjoyed volunteering with the Children’s Miracle Network and coaching youth sports. Dr. Magliochetti holds B.S. and Ph.D. degrees in Chemical Engineering from Northeastern University and the University of Massachusetts at Amherst, respectively, and a High Technology M.B.A. from Northeastern University.
Back to OBP Team
|
|